BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 8, 2004
View Archived Issues
PTC To Fund Drug Development Through $35M Financing Round
PTC Therapeutics Inc. raised $35 million to support its initial clinical drug development activities and other product research. (BioWorld Today)
Read More
Elan's Former Neurex Product, Prialt, Hits Phase III Endpoint
Read More
New Drug Efalizumab OK'd By FDA But Not As Definitive Cure; Psoriasis Still Plagues Legions
Read More
Thios Adds To Pipeline Through TS1 Licensing Deal With Wyeth
Read More
Forbes Medi-Tech Private Placement Raises $10.75M
Read More
Other News To Note
Read More